论文部分内容阅读
肝脏是结直肠癌转移最常见的靶器官,>50%的结直肠癌病人会在其病程中出现肝脏转移,2/3的结直肠癌病人因为肝脏转移而死亡。手术仍是结直肠癌肝转移(colorectal cancer liver metastases,CRLM)病人获得治愈的惟一方法~[1],5年存活率>50%,且有>20%的病人存活>10年。但是80%的CRLM病人初诊时为不可切除,且肝切除术后1年内复发率为30%~47%~[2-3]。多学科综合治疗协作组(multidis-
Liver is the most common target organ for metastatic colorectal cancer. More than 50% of patients with colorectal cancer will have liver metastases during their course of disease. Two-thirds of patients with colorectal cancer die of liver metastases. Surgery remains the only cure for colorectal cancer liver metastases (CRLM), [1] with a 5-year survival rate of> 50% and> 20% of patients surviving> 10 years. However, 80% of patients with CRLM are unresectable at first visit, and the recurrence rate within 1 year after hepatectomy is 30% -47%. Multidisciplinary collaborative treatment group (multidis-